Boston Partners’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-797,702
Closed -$17.2M 822
2025
Q4
$17.2M Sell
797,702
-630,251
-44% -$12.9M 0.02% 382
2025
Q3
$24.1M Buy
1,427,953
+8,335
+0.6% +$125K 0.02% 355
2025
Q2
$19.9M Sell
1,419,618
-562,271
-28% -$7.71M 0.02% 353
2025
Q1
$28M Buy
1,981,889
+25,536
+1% +$363K 0.03% 286
2024
Q4
$25.9M Buy
1,956,353
+393,600
+25% +$5.43M 0.03% 304
2024
Q3
$18.4M Sell
1,562,753
-128,947
-8% -$1.22M 0.02% 341
2024
Q2
$12.7M Sell
1,691,700
-94,734
-5% -$784K 0.02% 376
2024
Q1
$17.7M Buy
1,786,434
+453,254
+34% +$4.22M 0.02% 341
2023
Q4
$12.5M Buy
+1,333,180
New +$13.8M 0.02% 369
2022
Q3
Sell
-10,514
Closed -$221K 738
2022
Q2
$221K Sell
10,514
-11,680
-53% -$238K ﹤0.01% 668
2022
Q1
$521K Buy
22,194
+9,311
+72% +$228K ﹤0.01% 617
2021
Q4
$351K Buy
+12,883
New +$345K ﹤0.01% 633
2017
Q2
Sell
-42,384
Closed -$2.94M 770
2017
Q1
$2.94M Hold
42,384
﹤0.01% 602
2016
Q4
$2.83M Hold
42,384
﹤0.01% 623
2016
Q3
$2.81M Buy
+42,384
New +$2.9M ﹤0.01% 604
2015
Q4
Sell
-825,549
Closed -$63.4M 757
2015
Q3
$63.4M Buy
825,549
+100,074
+14% +$8.08M 0.1% 193
2015
Q2
$53.8M Buy
+725,475
New +$52.2M 0.08% 203

Other funds holding MD

Boston Partners's MD Position: Q1 2026 in Review

Boston Partners sold out of Pediatrix Medical (MD) in Q1 2026, closing a stake of 797,702 shares — an estimated $17.2M sold.

Boston Partners first reported a position in MD in Q2 2015 and held it in 17 quarters. The position peaked at $63.4M in Q3 2015. 297 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • Boston Partners reported no remaining Pediatrix Medical position as of Q1 2026 after selling out during the quarter.
  • Boston Partners sold 797,702 Pediatrix Medical shares in Q1 2026, an estimated $17.2M.
  • Boston Partners first reported a position in Pediatrix Medical in Q2 2015 and held it in 17 quarters.
  • Boston Partners's Pediatrix Medical position peaked at $63.4M in Q3 2015.
  • 297 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.